Pharmatech, Inc. Release: Denver Based Company Accelerates The Race To Cure Cancer By Improving How Clinical Trials Are Managed

DENVER, June 19, 2015 /PRNewswire/ -- The process of cancer clinical trials is broken. The majority of cancer patients in the U.S. have very limited access to the host of potentially life-saving clinical trials that are currently underway across the country. The investigational drugs they offer today in many cases will eventually become the standard of cancer treatment tomorrow. Yet more than 95% of patients who would qualify, never have the opportunity to participate in the clinical trials needed for the FDA to approve these modern anticancer drugs. The challenge with cancer clinical research is twofold. First, each trial is available at only a limited number of centers around the country. Second, patients receive care in a system of thousands of cancer centers and clinics that, if they conduct clinical trials at all, work independently from one another.

MD Anderson, Memorial Sloan Kettering, Cornell University just a few of the top cancer centers in the U.S., but unless you live near these centers or can afford to relocate for treatment, accessing world-class cancer clinical trials may be difficult. Denver based company Pharmatech is completely changing how clinical trials studies enroll cancer patients by offering a patient centered, on-demand research alternative. Pharmatech helps cancer patients identify the right trial opportunity, then activates that trial at a nearby treatment center using a Just-In-Time delivery model. The Just-In-Time research system was originally conceived by Pharmatech's founder Dr. Matthew Wiener, and its development has been supported by grants from the National Cancer Institute. According to Rob Bohacs, Pharmatech's CEO, "The process of developing patient-centric cancer trials is a breakthrough in helping both patients and pharmaceutical companies. Patient's would like to learn about clinical trials, but most can't relocate to Houston or New York just to be eligible for a trial, so why not bring the trial to the patient?"

Pharmatech's network of 300+ research sites (all independently owned) spans most of the U.S. The Just-In-Time system allows activation of any of the clinical trials in Pharmatech's portfolio, within 10 days of confirming patient interest and fit with a specific study. In addition, patients who are very interested in clinical trial participation can enroll in Pharmatech's AccessPPM protocol a molecular diagnostic registry that analyzes an individual's cancer related genetic mutations together with their clinical and treatment history to match the patient with the best next-generation, precision cancer medicine clinical trial treatment opportunities. 

The main challenge today is that patients cannot identify or easily connect with the right study. "Finding the right trials is incredibly complex for a physician, let alone a patient," according to Rob Bohacs. "Clinicaltrials.gov is simply unmanageable for patients as the terminology and specific information is difficult to interpret, hence why we are launching CureAccess.com a patient website that allows patients to receive weekly updates that pertain to their cancer type and where they may have that study opened. The website is set to go live by summer and will allow patients to setup a profile, receive weekly emails about clinical trials that match their disease, speak to one of our cancer experts, then refer themselves to a clinical trial center NEAR them." 

Major Pharmaceuticals are collaborating with Pharmatech to improve the process of clinical trials. 

About Pharmatech, Inc.
Pharmatech, Inc. is an oncology Contract Research Organization (CRO) that manages clinical trial processes. Through an organized network of cancer clinics, the company focuses on advancing the development of products for a broad range of pharmaceutical and biotechnology companies, and on promoting the inclusion of clinical trials in the spectrum of patient treatment options.

For more information about Pharmatech, please visit: http://www.pharmatech.com or contact us at pr@pharmatech.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/denver-based-company-accelerates-the-race-to-cure-cancer-by-improving-how-clinical-trials-are-managed-300101795.html

SOURCE Pharmatech, Inc.